chr16-21722919-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP6
The NM_144672.4(OTOA):c.1821G>A(p.Ala607Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,613,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144672.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 22Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_144672.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOA | NM_144672.4 | MANE Select | c.1821G>A | p.Ala607Ala | synonymous | Exon 18 of 29 | NP_653273.3 | ||
| OTOA | NM_001161683.2 | c.1584G>A | p.Ala528Ala | synonymous | Exon 13 of 24 | NP_001155155.1 | |||
| OTOA | NM_170664.3 | c.849G>A | p.Ala283Ala | synonymous | Exon 8 of 19 | NP_733764.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOA | ENST00000646100.2 | MANE Select | c.1821G>A | p.Ala607Ala | synonymous | Exon 18 of 29 | ENSP00000496564.2 | ||
| OTOA | ENST00000388958.8 | TSL:1 | c.1821G>A | p.Ala607Ala | synonymous | Exon 17 of 28 | ENSP00000373610.3 | ||
| OTOA | ENST00000286149.8 | TSL:5 | c.1863G>A | p.Ala621Ala | synonymous | Exon 17 of 28 | ENSP00000286149.4 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152162Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000994 AC: 25AN: 251384 AF XY: 0.000103 show subpopulations
GnomAD4 exome AF: 0.0000540 AC: 79AN: 1461828Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000138 AC: 21AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74334 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge
not specified Benign:1
p.Ala607Ala in exon 17 of OTOA: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 6/6612 Finnish chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP dbSNP rs143993346).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at